BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 28906295)

  • 1. Caution When Assessing Immunity to Varicella Through Antibody Testing in Patients with Inflammatory Bowel Disease.
    Caldera F; Wasan SK; Farraye FA; Hayney MS
    Inflamm Bowel Dis; 2017 Oct; 23(10):E50-E51. PubMed ID: 28906295
    [No Abstract]   [Full Text] [Related]  

  • 2. Use and limitations of varicella-zoster virus-specific serological testing to evaluate breakthrough disease in vaccinees and to screen for susceptibility to varicella.
    Breuer J; Schmid DS; Gershon AA
    J Infect Dis; 2008 Mar; 197 Suppl 2():S147-51. PubMed ID: 18419389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The utility of serologic testing for varicella in an adolescent population.
    Heininger U
    Vaccine; 2002 Feb; 20(11-12):1480. PubMed ID: 11858852
    [No Abstract]   [Full Text] [Related]  

  • 4. PROTECTIVE LEVELS OF VARICELLA-ZOSTER ANTIBODY DID NOT EFFECTIVELY PREVENT CHICKENPOX IN AN X-LINKED AGAMMAGLOBULINEMIA PATIENT.
    Nobre FA; Gonzalez IG; de Moraes-Pinto MI; Costa-Carvalho BT
    Rev Inst Med Trop Sao Paulo; 2015; 57(5):455-7. PubMed ID: 26603238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abortive chickenpox.
    Aksoy L; Ciftçi U; Ozsoylu S
    Eur J Pediatr; 1997 Mar; 156(3):248. PubMed ID: 9083772
    [No Abstract]   [Full Text] [Related]  

  • 6. Humoral and cellular immunity to varicella-zoster virus: an overview.
    Arvin AM
    J Infect Dis; 2008 Mar; 197 Suppl 2():S58-60. PubMed ID: 18419410
    [No Abstract]   [Full Text] [Related]  

  • 7. Varicella vaccine revisited.
    Seward J; Jumaan A; Schmid S
    Nat Med; 2000 Dec; 6(12):1298-300. PubMed ID: 11100088
    [No Abstract]   [Full Text] [Related]  

  • 8. Varicella immunity in vaccinated healthcare workers.
    Behrman A; Lopez AS; Chaves SS; Watson BM; Schmid DS
    J Clin Virol; 2013 Jun; 57(2):109-14. PubMed ID: 23434396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience and reason: twenty-year follow-up of protective immunity of the Oka strain live varicella vaccine.
    Asano Y; Suga S; Yoshikawa T; Kobayashi I; Yazaki T; Shibata M; Tsuzuki K; Ito S
    Pediatrics; 1994 Oct; 94(4 Pt 1):524-6. PubMed ID: 7936864
    [No Abstract]   [Full Text] [Related]  

  • 10. Varicella and herpes zoster appearing over sites of tinea corporis, hitherto unreported examples of immunocompromised districts: a case series.
    Verma SB; Gupta S; Yadav A; Ruocco E
    Int J Dermatol; 2020 Jun; 59(6):758-759. PubMed ID: 32072634
    [No Abstract]   [Full Text] [Related]  

  • 11. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of tolerance and effectiveness of a varicella vaccine in leukemic children.
    Bancillon A; Leblanc T; Baruchel A; Schaison G; Leverger G; Mallarmey D; Teuliere L
    Nouv Rev Fr Hematol (1978); 1991; 33(6):555-6. PubMed ID: 1667953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaccination against varicella: what's the point?
    Gershon AA
    Adv Exp Med Biol; 2010; 659():83-7. PubMed ID: 20204757
    [No Abstract]   [Full Text] [Related]  

  • 14. Controlling varicella in the healthcare setting: barriers to varicella vaccination among healthcare workers.
    Qureshi M; Gordon SM; Yen-Lieberman B; Litaker DG
    Infect Control Hosp Epidemiol; 1999 Jul; 20(7):516-8. PubMed ID: 10432167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Varicella seroepidemiology in United States air force recruits: A retrospective cohort study comparing immunogenicity of varicella vaccination and natural infection.
    Duncan JR; Witkop CT; Webber BJ; Costello AA
    Vaccine; 2017 Apr; 35(18):2351-2357. PubMed ID: 28359621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe chickenpox during treatment with corticosteroids. Latex assay shows false negatives.
    Bendig J; Meurisse V; Chambers S
    BMJ; 1995 Feb; 310(6975):327-8. PubMed ID: 7866186
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistence of protective immunity after inoculation with live varicella vaccine (strain Oka).
    Asano Y; Nagai T; Miyata T; Yazaki T; Ito S; Yamanishi K; Takahashi M
    Biken J; 1984 Sep; 27(2-3):123-8. PubMed ID: 6100049
    [No Abstract]   [Full Text] [Related]  

  • 18. Varicella infection caused by Oka strain vaccine in a heart transplant recipient.
    Kraft JN; Shaw JC
    Arch Dermatol; 2006 Jul; 142(7):943-5. PubMed ID: 16847227
    [No Abstract]   [Full Text] [Related]  

  • 19. Early detection of Varicella-Zoster virus (VZV)-specific T-cells before seroconversion in primary varicella infection: case report.
    Baiker A; Haase R; Eberle J; Vizoso Pinto MG; Pfrepper KI; Petrich A; Deml L; Campe H; Nitschko H; Jaeger G
    Virol J; 2010 Mar; 7():54. PubMed ID: 20205920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Varicella-zoster virus-specific cellular immunity in subjects given acyclovir after household chickenpox exposure.
    Kumagai T; Kamada M; Igarashi C; Yuri K; Furukawa H; Chiba S; Kojima H; Saito A; Okui T; Yano S
    J Infect Dis; 1999 Sep; 180(3):834-7. PubMed ID: 10438374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.